L type Ca<sup>2+ </sup>channel blockers prevent oxaliplatin-induced cold hyperalgesia and TRPM8 overexpression in rats

L type Ca<sup>2+ </sup>channel blockers prevent oxaliplatin-induced cold hyperalgesia and TRPM8 overexpression in rats

<p>Abstract</p> <p>Background</p> <p>Oxaliplatin is an important drug used in the treatment of colorectal cancer. However, it frequently causes severe acute and chronic peripheral neuropathies. We recently reported that repeated administration of oxaliplatin induced col...

Full description

Bibliographic Details
Main Authors:	Kawashiri Takehiro, Egashira Nobuaki, Kurobe Kentaro, Tsutsumi Kuniaki, Yamashita Yuji, Ushio Soichiro, Yano Takahisa, Oishi Ryozo
Format:	Article
Language:	English
Published:	SAGE Publishing 2012-01-01
Series:	Molecular Pain
Online Access:	http://www.molecularpain.com/content/8/1/7

Similar Items

Inhibition of Ca<sup>2+</sup>/Calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in Rats
by: Shirahama Masafumi, et al.
Published: (2012-04-01)

Repeated Administration of Amitriptyline Reduces Oxaliplatin-Induced Mechanical Allodynia in Rats
by: Hikaru Sada, et al.
Published: (2012-01-01)

Mexiletine Reverses Oxaliplatin-Induced Neuropathic Pain in Rats
by: Nobuaki Egashira, et al.
Published: (2010-01-01)

Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats.
by: Shunsuke Fujita, et al.
Published: (2015-01-01)

Comparison of Peripheral Neuropathy Induced by Standard and Nanoparticle Albumin–Bound Paclitaxel in Rats
by: Yuji Yamashita, et al.
Published: (2011-01-01)

Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence
by: Takehiro Kawashiri, et al.
Published: (2021-01-01)

Behavioral and pharmacological characteristics of bortezomib-induced peripheral neuropathy in rats
by: Shota Yamamoto, et al.
Published: (2015-09-01)

Goshajinkigan reduces bortezomib-induced mechanical allodynia in rats: Possible involvement of kappa opioid receptor
by: Hitomi Higuchi, et al.
Published: (2015-11-01)

Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity
by: Kuniaki Tsutsumi, et al.
Published: (2016-06-01)

Ibudilast suppresses oxaliplatin-induced mechanical allodynia and neurodegeneration in rats
by: Nobuaki Egashira, et al.
Published: (2021-09-01)

Gabapentin Prevents Oxaliplatin-Induced Mechanical Hyperalgesia in Mice
by: Masahiro Ohsawa, et al.
Published: (2014-01-01)

A Central Role for TRPM4 in Ca<sup>2+</sup>-Signal Amplification and Vasoconstriction
by: Tamás Csípő, et al.
Published: (2022-01-01)

Characteristics of Gabexate Mesilate–Induced Cell Injury in Porcine Aorta Endothelial Cells
by: Tomoko Aki, et al.
Published: (2008-01-01)

Comparison of Injuring Effects of Vesicant, Irritant, and Nonvesicant Anticancer Drugs on Endothelial Cells
by: Takaaki Yamada, et al.
Published: (2011-01-01)

Oxaliplatin Causes Transient Changes in TRPM8 Channel Activity
by: Vittoria Rimola, et al.
Published: (2021-05-01)

Reactive Oxygen Species-Induced TRPM2-Mediated Ca<sup>2+</sup> Signalling in Endothelial Cells
by: Ran Ding, et al.
Published: (2021-05-01)

Omeprazole Suppresses Oxaliplatin-Induced Peripheral Neuropathy in a Rodent Model and Clinical Database
by: Keisuke Mine, et al.
Published: (2022-08-01)

In Vitro Study of the Multimodal Effect of Na<sup>+</sup>/K<sup>+</sup> ATPase Blocker Ouabain on the Tumor Microenvironment and Malignant Cells
by: Octavia-Oana Harich, et al.
Published: (2023-08-01)

Protective Effects of Amino Acids Against Gabexate Mesilate–Induced Cell Injury in Porcine Aorta Endothelial Cells
by: Tomoko Aki, et al.
Published: (2008-01-01)

Exacerbated Neuropathy in POLAR A and M Trials Due to Redox Interaction of PledOx-Associated Mn<sup>2+</sup> and Oxaliplatin-Associated Pt<sup>2+</sup>
by: Jan Olof G. Karlsson, et al.
Published: (2023-03-01)

Molecular Modeling and Potential Ca<sup>2+</sup> Channel Blocker Activity of Diphenylmethoxypiperidine Derivatives
by: Victor M. Pulgar, et al.
Published: (2023-03-01)

Preclinical and Clinical Evidence of Therapeutic Agents for Paclitaxel-Induced Peripheral Neuropathy
by: Takehiro Kawashiri, et al.
Published: (2021-08-01)

Development of selective blockers for Ca<sup>2+</sup>-activated Cl<sup>- </sup>channel using <it>Xenopus laevis </it>oocytes with an improved drug screening strategy
by: Oh Soo-Jin, et al.
Published: (2008-10-01)

TRPM7-Mediated Ca<sup>2+</sup> Regulates Mussel Settlement through the CaMKKβ-AMPK-SGF1 Pathway
by: Jian He, et al.
Published: (2023-03-01)

Inhibition of the Hepatic Uptake of <sup>99m</sup>Tc-Tetrofosmin Using an Organic Cation Transporter Blocker
by: Kodai Nishi, et al.
Published: (2021-07-01)

Oxaliplatin-Induced Senescence in Colorectal Cancer Cells Depends on p14<sup>ARF</sup>-Mediated Sustained p53 Activation
by: Maja T. Tomicic, et al.
Published: (2021-04-01)

Donepezil ameliorates oxaliplatin-induced peripheral neuropathy via a neuroprotective effect
by: Takehiro Kawashiri, et al.
Published: (2019-07-01)

Simultaneous Expression of Th1- and Treg-Associated Chemokine Genes and CD4<sup>+</sup>, CD8<sup>+</sup>, and Foxp3<sup>+</sup> Cells in the Premalignant Lesions of 4NQO-Induced Mouse Tongue Tumorigenesis
by: Hana Yamaguchi, et al.
Published: (2021-04-01)

The Ca<sup>2+</sup> Channel Blocker Verapamil Inhibits the In Vitro Activation and Function of T Lymphocytes: A 2022 Reappraisal
by: José Ignacio Veytia-Bucheli, et al.
Published: (2022-07-01)

A Novel Cu<sup>2+</sup> Quantitative Detection Nucleic Acid Biosensors Based on DNAzyme and “Blocker” Beacon
by: Hanyue Zhang, et al.
Published: (2023-04-01)

New Topics in Vasopressin Receptors and Approach to Novel Drugs: Role of the Vasopressin Receptor in Psychological and Cognitive Functions
by: Nobuaki Egashira, et al.
Published: (2009-01-01)

Riluzole prevents oxaliplatin-induced cold allodynia via inhibition of overexpression of transient receptor potential melastatin 8 in rats
by: Shota Yamamoto, et al.
Published: (2018-11-01)

Clinical and Experimental Evidence for Prevention of Acute Renal Failure Induced by Radiographic Contrast Media
by: Yoshinori Itoh, et al.
Published: (2005-01-01)

Organomonophosphines in Pt(η<sup>3</sup>-X<sup>1</sup>X<sup>2</sup>X<sup>3</sup>)(PR<sub>3</sub>), (X = N<sup>1</sup>, N<sup>2</sup>, N<sup>3</sup>; S<sup>1</sup>, S<sup>2</sup>, S<sup>3</sup>; or Te<sup>1</sup>, Te<sup>2</sup>, Te<sup>3</sup>) Derivatives: Structural Aspects
by: Milan Melník, et al.
Published: (2023-06-01)

Effects of Oxaliplatin on Facial Sensitivity to Cool Temperatures and TRPM8 Expressing Trigeminal Ganglion Neurons in Mice
by: Robert M. Caudle, et al.
Published: (2022-05-01)

Heterotridentate Organomonophosphines in Pt(κ<sup>3</sup>–X<sup>1</sup>P<sup>1</sup>X<sup>2</sup>)(Y) (X<sup>1,2</sup> = N<sup>1,2</sup> or S<sup>1,2</sup>), Pt(κ<sup>3</sup>–P<sup>1</sup>N<sup>1</sup>X<sup>1</sup>)(Y) (X<sup>1</sup> = O, C, S or Se) Pt(κ<sup>3</sup>–P<sup>1</sup>S<sup>1</sup>Cl<sup>1</sup>)(Cl) and Pt(κ<sup>3</sup>–P<sup>1</sup>Si<sup>1</sup>N<sup>1</sup>)(OL)—Structural Aspects
by: Milan Melník, et al.
Published: (2022-12-01)

Erucic Acid-Rich Yellow Mustard Oil Improves Insulin Resistance in KK-A<sup>y</sup> Mice
by: Asako Takahashi, et al.
Published: (2021-01-01)

Inhibited and Retarded Behavior by Ca<sup>2+</sup> and Ca<sup>2+</sup>/OD Loading Rate on Ureolytic Bacteria in MICP Process
by: Masaharu Fukue, et al.
Published: (2023-04-01)

Ultra-violet absorption cross sections of isotopically substituted nitrous oxide species: <sup>14</sup>N<sup>14</sup>NO, <sup>15</sup>N<sup>14</sup>NO, <sup>14</sup>N<sup>15</sup>NO and <sup>15</sup>N<sup>15</sup>NO
by: P. von Hessberg, et al.
Published: (2004-01-01)

Search for CP violation through an amplitude analysis of D <sup>0</sup> → K <sup>+</sup> K <sup>−</sup> π <sup>+</sup> π <sup>−</sup> decays
Published: (2021)